Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Mild tenderness at the injection or IV site is possible
Cholesterol impact represents the primary concern, with HDL cholesterol often decreasing while LDL may increase
Trial status (May 2026): Eli Lilly reported positive topline results from the Phase 3 TRIUMPH-1 obesity trial on May 21, 2026, with mean weight reduction of 28.3% at 80 weeks on the 12 mg arm [1][2]
Coverage for Ozempic for weight loss (as opposed to type 2 diabetes) is variable
US$ 27.95
US$ 22.62
US$ 24.67
US$ 28.78
US$ 28.41
